“Omics” and Immunologic Approaches to Optimizing Cure Rates in HER2-Positive Breast Carcinomas

Podobne knjige/članki

• Omics and immunologic approaches to optimizing cure rates in HER2-positive breast carcinomas.
  od: Elda eTagliabue, et al.
  Izdano: (2014-11-01)
• Identification of HER2-positive breast carcinomas as a particular subset with peculiar clinical behaviours
  od: Casalini, P, et al.
  Izdano: (2001)
• Extracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab Treatment
  od: Rybinska, Ilona, et al.
  Izdano: (2020)
• Rescue of HER-2-positive breast carcinoma cells from dormancy by growth factors produced during wound healing
  od: Agresti, R, et al.
  Izdano: (2001)
• Optimizing the management of her2-positive early breast cancer: the clinical reality
  od: Verma, Su., et al.
  Izdano: (2010)